Q2 2014 Holdings
Filed 2014-08-14 | 15 holdings | $11.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $11.3M | 182,300 | 98.2% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $60.6K | 4,919,625 | 0.5% |
| PDL Biopharma Inc | NOTE 2.875% 2/15/15 | 69329YAE4 | $47.9K | $25,974,000 | 0.4% |
| Salix Pharmaceuticals Inc | COM | 795435106 | $37.0K | 300,000 | 0.3% |
| Opko Health Inc | NOTE 3.0% 2/1/33 | 68375NAA1 | $18.7K | $14,000,000 | 0.2% |
| Horizon Pharma Inc | COM | 44047T109 | $15.8K | 1,000,000 | 0.1% |
| LA Jolla Pharmaceutical Co(LJPC) | COM | 503459604 | $8.1K | 881,907 | 0.1% |
| Merrimack Pharmaceuticals Inc | NOTE 4.5% 7/15/20 | 590328AA8 | $7.5K | $5,500,000 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $5.8K | 288,432 | 0.1% |
| Endocyte Inc | COM | 29269A102 | $3.1K | 465,763 | 0.0% |
| Dendreon Corp | COM | 24823Q107 | $128 | 55,548 | 0.0% |
| Ambit Biosciences Corp | COM | 02318X100 | $0 | 46 | 0.0% |